Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

Clinical Trial: Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement - Open Trial

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07755527) titled 'Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement - Open Tri... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More

Clinical Trial: Diaphragm-Pelvic Floor Synergy Training in Young Females With Primary Dysmenorrhea.

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754305) titled 'Diaphragm-Pelvic Floor Synergy Training in Young Females With Primary Dysmenorrhea.' on Aug... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Clinical Trial: Priming Using Contrast Training Exercise

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07754669) titled 'Priming Using Contrast Training Exercise' on Aug. 04. Brief Summary: This study investigat... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, Aug. 11 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More

Clinical Trial: A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradenitis Suppurativa

U.S., Aug. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07756346) titled 'A Study to Evaluate the Efficacy of Botulinum Toxin in Patients With Hidradenitis Suppurati... Read More

• ««
• «
• 1647
• 1648
• 1649
• 1650
• 1651
• 1652
• 1653
• 1654
• 1655
• 1656
• »
• »»